Lixte Biotechnology Holdings Inc (LIXT)
2.93
+0.04
(+1.38%)
USD |
NASDAQ |
May 06, 11:18
Lixte Biotechnology Holdings Shareholders Equity (Quarterly): 3.995M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.995M |
September 30, 2023 | 4.923M |
June 30, 2023 | 2.692M |
March 31, 2023 | 4.081M |
December 31, 2022 | 5.165M |
September 30, 2022 | 6.411M |
June 30, 2022 | 7.492M |
March 31, 2022 | 3.473M |
December 31, 2021 | 4.790M |
September 30, 2021 | 6.075M |
June 30, 2021 | 6.866M |
March 31, 2021 | 7.648M |
December 31, 2020 | 5.012M |
September 30, 2020 | 1.141M |
June 30, 2020 | 1.678M |
March 31, 2020 | 2.051M |
December 31, 2019 | 2.434M |
September 30, 2019 | 2.756M |
June 30, 2019 | 3.396M |
March 31, 2019 | 3.71M |
December 31, 2018 | 4.126M |
September 30, 2018 | -0.0141M |
June 30, 2018 | 0.2445M |
March 31, 2018 | 0.6159M |
December 31, 2017 | 0.995M |
Date | Value |
---|---|
September 30, 2017 | 1.395M |
June 30, 2017 | 1.823M |
March 31, 2017 | 0.6661M |
December 31, 2016 | 0.2148M |
September 30, 2016 | 0.738M |
June 30, 2016 | 1.239M |
March 31, 2016 | 1.032M |
December 31, 2015 | 0.3123M |
September 30, 2015 | 0.8049M |
June 30, 2015 | 1.327M |
March 31, 2015 | 1.428M |
December 31, 2014 | 0.2659M |
September 30, 2014 | 0.5939M |
June 30, 2014 | 0.975M |
March 31, 2014 | -0.0963M |
December 31, 2013 | 0.2363M |
September 30, 2013 | 0.5803M |
June 30, 2013 | 0.8787M |
March 31, 2013 | 1.211M |
December 31, 2012 | 1.492M |
September 30, 2012 | 1.715M |
June 30, 2012 | 1.903M |
March 31, 2012 | -0.2656M |
December 31, 2011 | 0.079M |
September 30, 2011 | 0.6381M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.141M
Minimum
Sep 2020
7.648M
Maximum
Mar 2021
4.32M
Average
4.081M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
iBio Inc | 9.197M |
PAVmed Inc | -53.83M |
PDS Biotechnology Corp | 26.13M |
Moleculin Biotech Inc | 26.07M |
Syros Pharmaceuticals Inc | 16.66M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 4.309M |
Total Liabilities (Quarterly) | 0.3139M |